Follow
Hosein Nouri
Hosein Nouri
Verified email at res.mui.ac.ir
Title
Cited by
Cited by
Year
COVID-19 and the risk of relapse in multiple sclerosis patients: a fight with no bystander effect?
M Etemadifar, N Sedaghat, A Aghababaee, PK Kargaran, MR Maracy, ...
Multiple Sclerosis and Related Disorders 51, 102915, 2021
472021
Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient
M Etemadifar, AA Sigari, N Sedaghat, M Salari, H Nouri
Human Vaccines & Immunotherapeutics 17 (10), 3481-3483, 2021
362021
Risk factors of severe COVID-19 in people with multiple sclerosis: A systematic review and meta-analysis
M Etemadifar, H Nouri, MR Maracy, AA Sigari, M Salari, Y Blanco, ...
Revue neurologique 178 (1-2), 121-128, 2022
282022
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
M Etemadifar, H Nouri, M Pitzalis, ML Idda, M Salari, M Baratian, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (9), 986-994, 2022
272022
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine
M Etemadifar, N Sedaghat, H Nouri, N Lotfi, A Chitsaz, R Khorvash, ...
Multiple Sclerosis and Related Disorders 57, 103417, 2022
212022
MRI signs of CNS demyelinating diseases
M Etemadifar, H Ashourizadeh, H Nouri, PK Kargaran, M Salari, M Rayani, ...
Multiple Sclerosis and Related Disorders 47, 102665, 2021
182021
Movement Disorders Associated with COVID-19
M Salari, B Zaker Harofteh, M Etemadifar, N Sedaghat, H Nouri
Parkinson’s Disease 2021, 2021
162021
Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
M Etemadifar, AP Abhari, H Nouri, M Salari, S Maleki, A Amin, ...
BMC neurology 22 (1), 64, 2022
142022
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
M Etemadifar, AP Abhari, H Nouri, AA Sigari, SM Piran Daliyeh, ...
Human vaccines & immunotherapeutics 18 (1), 2041945, 2022
132022
Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an …
M Etemadifar, H Nouri, M Salari, N Sedaghat
Human vaccines & immunotherapeutics 18 (1), 2033540, 2022
112022
Post-COVID-19 acute disseminated encephalomyelitis: case report and review of the literature
M Etemadifar, AR Mansouri, H Nouri, N Sedaghat, M Salari, M Maghsoudi, ...
Neuroimmunology Reports 2, 100066, 2022
112022
Conus medullaris involvement in demyelinating disorders of the CNS: a comparative study
M Etemadifar, M Salari, PK Kargaran, AA Sigari, H Nouri, F Etemadifar, ...
Multiple Sclerosis and Related Disorders 54, 103127, 2021
112021
Retinal ischemic cascade: new insights into the pathophysiology and imaging findings
SH Abtahi, R Nourinia, M Mazloumi, H Nouri, JF Arevalo, H Ahmadieh
Survey of ophthalmology 68 (3), 380-387, 2023
92023
Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review.
S Fekri, M Khorshidifar, MS Dehghani, H Nouri, SH Abtahi
Journal Francais D'ophtalmologie, S0181-5512 (22) 00403, 2022
92022
Frequency of diencephalic syndrome in NMOSD
M Etemadifar, H Nouri, R Khorvash, M Salari, K Ghafari, A Aghababaee
Acta Neurologica Belgica, 1-7, 2022
92022
Autoimmune encephalitis: the first observational study from Iran
M Etemadifar, A Aghababaei, H Nouri, PK Kargaran, S Mohammadi, ...
Neurological Sciences, 1-10, 2021
62021
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review
M Etemadifar, M Fereidan-Esfahani, N Sedaghat, PK Kargaran, ...
Revue Neurologique 179 (6), 533-547, 2023
42023
Endogenous fungal endophthalmitis following COVID-19 hospitalization: evidence from a year-long observational study
S Fekri, M Khorshidifar, F Esfahanian, A Veisi, H Nouri, SH Abtahi
Journal francais d'ophtalmologie 46 (5), 461-467, 2023
42023
Smoking and environmental tobacco smoke exposure: implications in ocular disorders
S Karimi, H Nouri, S Mahmoudinejad-Azar, SH Abtahi
Cutaneous and ocular toxicology 42 (1), 1-7, 2023
42023
Eye disorders in the post-COVID era
SH Abtahi, H Nouri, S Moradian, S Yazdani, H Ahmadieh
Journal of Ophthalmic & Vision Research 16 (4), 527, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20